Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of immune-related and inflammatory diseases

Treatment of immune-related and inflammatory diseases

US Patent 10919883 · Granted Feb 16, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating systemic lupus erythematosus and the use of biomarkers as a2024
Transgenic mouse expressing human cereblon2024
3-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dion2023
Methods, system and computer program product for selectively responding to prese2023
Treatment of immune-related and inflammatory diseases2022
Treatment of immune-related and inflammatory diseases2022
Treatment of immune-related and inflammatory diseases2022
Combination therapies comprising apremilast and Tyk2 inhibitors2022
(+)-2-[1-(3-Ethoxy-4- methoxyphenyl)-2-methylsulfonylethyl]- 4-acetylaminoisoind2022
Treatment of cancer with TOR kinase inhibitors2021
Methods, systems, and networks for authentication based on physical condition of2021
Substitute redundant memory2021